Vaccine against uterine cancer soon on market of Serbia?
Company "Merck Sharp & Dohme" (MSD), which has been present on the local market since 1996, works on the obtaining of the approval for sale of revolutionary vaccine against uterine cancer named "Silgard" in Serbia.
Let us remind that the Advisory Board for Immunization of the American CEnter for Control and Prevention of Diseases unanimously backed the recommendation that the girls and women, aged between 11 and 26, should be vaccinated with the MSD vaccine, which is called "gardasil" in USA. Company "Merck" tested "gardasil" on 27,000 women in 33 countries and the results of the clinical testing showed that the vaccine was 100% efficient aggainst the viruses that are responsilbe for 70% of infections caused by human papilloma virus.
By the way, the uterine cancer is the second most often type of that women's disease. Every year, half million new cases are registered.
Most Important News
11.03.2024. | Healthcare
Are Marketing Experts Reading Our Minds? – eKapija Investigates: What Neuromarketing Is and How Much It Is Used in Serbia
11.03.2024. | Construction, Transport
Tender for Continuation of Construction of Patrijarha Pavla Blvd Stopped – Contractors Demanding Price Higher Than Estimated
11.03.2024. | Construction, Transport
11.03.2024. | Construction, IT, Telecommunications
Auction for 5G Network by End-Year, Minister Announces
11.03.2024. | Construction, IT, Telecommunications
28.03.2024. | Construction
Beginning of Construction of First “Green Dam” in Serbia Which Will Supply 500,000 People with Drinking Water
28.03.2024. | Construction
17.01.2024. | Industry, Healthcare
Ceremony of Opening of Centers of Excellence in Kragujevac Planned for Spring – Official Beginning of Operations in June
17.01.2024. | Industry, Healthcare
27.03.2024. | Industry, Transport, Finance
City to Waive Over 30 Zemun and Palilula Bus Lines to Private Transporters – Draft Public-Private Partnership for 10-Year Period Ready, Job Worth Half a Billion Euros
27.03.2024. | Industry, Transport, Finance